Renivace and agranulocytosis 
Renivace and agranulocytosis Patient Reports February 13, 2012
Renivace Side Effects Report #4767736-4
Renivace side effect was reported by a Pharmacist from JAPAN on Aug 25, 2005. Female patient, 80 years of age, was diagnosed with hypertension, nocturia, insomnia, epilepsy
and was treated with Renivace. After drug was administered, patient experienced the following side effects: agranulocytosis, basophil percentage decreased, blood alkaline phosphatase increased, c-reactive protein increased, condition aggravated, dysuria, eosinophil percentage decreased, gamma-glutamyltransferase increased, lymphocyte percentage increased. Renivace dosage: 5 MG QD PO. During the same period patient was treated with TRYPTANOL, MYSLEE, TEGRETOL, GASTER, MAGMITT, PURSENNID, AMLODIN, CLARITIN. Patient was hospitalized. Patient recovered.Renivace Side Effects Report #4775021-X
Renivace side effect was reported by a Physician from JAPAN on Sept 02, 2005. Female patient, 80 years of age, was diagnosed with hypertension, nocturia, insomnia, epilepsy
and was treated with Renivace. After drug was administered, patient experienced the following side effects: agranulocytosis, basophil percentage decreased, blood alkaline phosphatase increased, c-reactive protein increased, dysuria, eosinophil percentage decreased, epilepsy , gamma-glutamyltransferase increased, lymphocyte percentage increased. Renivace dosage: 5 MG QD PO. During the same period patient was treated with TRYPTANOL, MYSLEE, TEGRETOL, GASTER, MAGMITT, PURSENNID, AMLODIN, CLARITIN. Patient was hospitalized. Patient recovered.Renivace Side Effects Report #4796542-X
Renivace side effect was reported by a Physician from JAPAN on Sept 21, 2005. Female patient, 80 years of age, was diagnosed with hypertension, nocturia, insomnia, epilepsy
, gastric ulcer and was treated with Renivace. After drug was administered, patient experienced the following side effects: agranulocytosis, blood alkaline phosphatase increased, c-reactive protein increased, condition aggravated, cystitis, dysuria, epilepsy , gamma-glutamyltransferase increased, nocturia. Renivace dosage: 5 MG QD PO. During the same period patient was treated with TRYPTANOL, MYSLEE, TEGRETOL, GASTER, AMLODIPINE BESYLATE, CLARITIN, MAGMITT, NORVASC. Patient was hospitalized. Patient recovered.Renivace Side Effects Report #4627908-6
Renivace side effect was reported by a Physician from on Mar 16, 2005. Female patient, 70 years of age, weighting 125.7 lb, was diagnosed with hypertension, myocardial infarction, atrial fibrillation
, diabetes mellitus and was treated with Renivace. After drug was administered, patient experienced the following side effects: agranulocytosis, alanine aminotransferase abnormal, aspartate aminotransferase abnormal, blood alkaline phosphatase abnormal, blood lactate dehydrogenase abnormal, gamma-glutamyltransferase abnormal, haematocrit abnormal, haemoglobin abnormal, monocyte count abnormal. Renivace dosage: 2.5 MG BID PO. During the same period patient was treated with PANALDINE, BEPRICOL, AMARYL, ASPIRIN, WARFARIN, ARTIST, MUCOSTA, MAGNESIUM OXIDE. Patient recovered.Renivace Side Effects Report #4650539-9
Renivace side effect was reported by a Physician from on Apr 14, 2005. Female patient, 70 years of age, weighting 125.7 lb, was diagnosed with hypertension, myocardial infarction, atrial fibrillation
, diabetes mellitus and was treated with Renivace. After drug was administered, patient experienced the following side effects: agranulocytosis, alanine aminotransferase abnormal, aspartate aminotransferase abnormal, blood alkaline phosphatase abnormal, blood lactate dehydrogenase abnormal, gamma-glutamyltransferase abnormal, neutrophil count increased, prothrombin time abnormal. Renivace dosage: 2.5 MG BID PO. During the same period patient was treated with PANALDINE, BEPRICOL, AMARYL, ASPIRIN, WARFARIN, ARTIST, MUCOSTA, MAGNESIUM OXIDE. Patient recovered.Renivace Side Effects Report #4751764-9
Renivace side effect was reported by a Pharmacist from JAPAN on Aug 04, 2005. Female patient, 80 years of age, was treated with Renivace. After drug was administered, patient experienced the following side effects: agranulocytosis. Renivace dosage: 5 MG QD PO. During the same period patient was treated with TRYPTANOL, AMLODIN, MAGMITT, GASTER, PURSENNID, TEGRETOL, CLARITHROMYCIN, MYSLEE. Patient was hospitalized. Patient recovered.
Renivace Side Effects Report #4757799-4
Renivace side effect was reported by a Pharmacist from JAPAN on Aug 12, 2005. Female patient, 80 years of age, was diagnosed with nocturia, insomnia, epilepsy
and was treated with Renivace. After drug was administered, patient experienced the following side effects: agranulocytosis, basophil count decreased, blood alkaline phosphatase increased, dysuria, eosinophil count decreased, gamma-glutamyltransferase increased, lymphocyte count increased, monocyte count decreased, neutrophil count decreased. Renivace dosage: 5 MG QD PO. During the same period patient was treated with TRYPTANOL, MYSLEE, TEGRETOL, GASTER, MAGMITT, PURSENNID, AMLODIN, CLARITIN. Patient was hospitalized. Patient recovered.